Jerzy Karczewski
Fraunhofer USA
Biography
Dr. Karczewski received his Ph.D. in Biochemistry from Medical University of Lodz, Poland., After coming to the US he joined Biochemistry Department at Merck Research Laboratories, West Point Pa., where he made numerous contributions to drug discovery efforts, including discovery of novel natural product- and antibody-based inhibitors of intergrins and invented high throughput screening methods which led to discovery of novel inhibitors of cardiac ion channels and other pharmaceutically relevant targets. In 2009 Dr. Karczewski moved to Vaccines Basic Research (also at Merck Research Laboratories) where his research was aimed at discovering novel recombinant vaccines and biologics against bacterial and viral pathogens, including Clostridium Difficile, Chlamydia, RSV, CMV and Neisseria meningiditis. In 2014 Dr. Karczewski joined Fraunhofer Center for Molecular Biotechnology where he supports several projects focusing on plant-based vaccines and monoclonal antibodies.
Abstract
Abstract : Plant-based expression of therapeutic monoclonal antibodies targeting viral and bacterial infections